EC Number | Activating Compound | Comment | Organism | Structure |
---|---|---|---|---|
3.4.17.20 | thrombin | activation | Homo sapiens | |
3.4.17.20 | Thrombomodulin | activation | Homo sapiens |
EC Number | Cloned (Comment) | Organism |
---|---|---|
3.4.17.20 | expression in BHK-cells | Homo sapiens |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.4.17.20 | 2-Guanidinoethylmercaptosuccinic acid | i.e. GEMSA | Homo sapiens | |
3.4.17.20 | 6-aminohexanoic acid | - |
Homo sapiens | |
3.4.17.20 | potato carboxypeptidase inhibitor | - |
Homo sapiens |
EC Number | KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
3.4.17.20 | 3.41 | - |
N-[3-(2-Furylacryloyl)]-L-Ala-L-Lys | recombinant enzyme | Homo sapiens | |
3.4.17.20 | 4.71 | - |
N-[3-(2-Furylacryloyl)]-L-Ala-L-Lys | plasma-derived enzyme | Homo sapiens | |
3.4.17.20 | 766 | - |
Hippuryl-L-Lys | plasma-derived enzyme | Homo sapiens | |
3.4.17.20 | 783 | - |
hippuryl-L-Arg | recombinant enzyme | Homo sapiens | |
3.4.17.20 | 817 | - |
hippuryl-L-Arg | plasma-derived enzyme | Homo sapiens | |
3.4.17.20 | 933 | - |
Hippuryl-L-Lys | recombinant enzyme | Homo sapiens |
EC Number | Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|---|
3.4.17.20 | 12000 | - |
x * 25000 + x * 12000, derived by cleavage at Arg330, inactive form, SDS-PAGE | Homo sapiens |
3.4.17.20 | 25000 | - |
x * 25000 + x * 12000, derived by cleavage at Arg330, inactive form, SDS-PAGE | Homo sapiens |
3.4.17.20 | 35000 | - |
x * 35000, active enzyme | Homo sapiens |
3.4.17.20 | 46000 | - |
x * 46000, enzymes rTAFI and pTAFI, deglycosylated enzymes, slight differences in MW might be due to differences in glycosylation, SDS-PAGE | Homo sapiens |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.4.17.20 | Fibrin, partially degraded + H2O | Homo sapiens | - |
? | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.4.17.20 | Homo sapiens | - |
- |
- |
EC Number | Purification (Comment) | Organism |
---|---|---|
3.4.17.20 | of cloned enzyme from BHK-cells | Homo sapiens |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
3.4.17.20 | plasma | - |
Homo sapiens | - |
EC Number | Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|---|
3.4.17.20 | 0.017 | - |
substrate hippuryl-L-Arg | Homo sapiens |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.4.17.20 | Fibrin, partially degraded + H2O | - |
Homo sapiens | Fibrin, partially degraded + L-Lys + L-Arg | - |
? | |
3.4.17.20 | Fibrin, partially degraded + H2O | - |
Homo sapiens | ? | - |
? | |
3.4.17.20 | Hippuryl-L-Arg + H2O | - |
Homo sapiens | Hippuric acid + L-Arg | - |
? | |
3.4.17.20 | Hippuryl-L-Lys + H2O | - |
Homo sapiens | Hippuric acid + L-Lys | - |
? | |
3.4.17.20 | N-[3-(2-Furylacryloyl)]-L-Ala-L-Lys + H2O | - |
Homo sapiens | N-[3-(2-Furylacryloyl)]-L-Ala + L-Lys | - |
? |
EC Number | Subunits | Comment | Organism |
---|---|---|---|
3.4.17.20 | ? | derived from zymogen by cleavage at Arg92, SDS-PAGE | Homo sapiens |
3.4.17.20 | ? | x * 25000 + x * 12000, derived by cleavage at Arg330, inactive form, SDS-PAGE | Homo sapiens |
3.4.17.20 | ? | x * 46000, enzymes rTAFI and pTAFI, deglycosylated enzymes, slight differences in MW might be due to differences in glycosylation, SDS-PAGE | Homo sapiens |
3.4.17.20 | ? | x * 35000, active enzyme | Homo sapiens |
EC Number | Temperature Stability Minimum [°C] | Temperature Stability Maximum [°C] | Comment | Organism |
---|---|---|---|---|
3.4.17.20 | - |
- |
enzyme pTAFI and rTAFI stable | Homo sapiens |
3.4.17.20 | 22 | - |
half-life 120-150 min | Homo sapiens |
3.4.17.20 | 30 | - |
half-life 40-50 min | Homo sapiens |
3.4.17.20 | 37 | - |
half-life 8-9 min, stable in presence of inhibitors 2-guanidinoethylmercaptosuccinic acid or 6-aminohexanoic acid | Homo sapiens |
EC Number | Turnover Number Minimum [1/s] | Turnover Number Maximum [1/s] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
3.4.17.20 | 40.7 | - |
Hippuryl-L-Lys | plasma-derived enzyme | Homo sapiens | |
3.4.17.20 | 45.6 | - |
Hippuryl-L-Lys | recombinant enzyme | Homo sapiens | |
3.4.17.20 | 52.4 | - |
hippuryl-L-Arg | plasma-derived enzyme | Homo sapiens | |
3.4.17.20 | 56.7 | - |
hippuryl-L-Arg | recombinant enzyme | Homo sapiens | |
3.4.17.20 | 248 | - |
N-[3-(2-Furylacryloyl)]-L-Ala-L-Lys | recombinant enzyme | Homo sapiens | |
3.4.17.20 | 293 | - |
N-[3-(2-Furylacryloyl)]-L-Ala-L-Lys | plasma-derived enzyme | Homo sapiens |